Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 206

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Development of TLR inhibitors for the treatment of autoimmune diseases

Barrat, Franck J., Coffman, Robert L.·2008·Immunological Reviews

Abstract

Summary The innate immune system is a critical element of protection from invading pathogens. The specific receptors that recognize various components of the pathogens trigger signals that result in the production of proinflammatory cytokines as well as the activation of antigen‐presenting cells, which activate the adaptive immune system. The discovery of the Toll‐like receptors (TLRs) as important components of pathogen recognition has brought new understanding of the key signaling molecules involves in innate immune activation. Interestingly, it appears that most TLRs can recognize self‐ligands as well and that mechanisms are required to discriminate between self and non‐self ligands. One of these mechanisms is the expression of all the nucleic acid‐specific TLR in endosomal compartments and not on the cell surface. Inappropriate activation of TLRs by self‐components can result in sterile inflammation or autoimmunity. For example, TLR7 and TLR9 activation by endogenous RNA and DNA, transported to the endosomes in the form of immune complexes or non‐covalently associated with cationic peptides, could be an important mechanism involved in promoting diseases such as systemic lupus erythematosus and psoriasis. In this review, we discuss the rationale for self‐recognition by TLR7 and TLR9 as an important part of the development of lupus and other autoimmune diseases. We describe novel inhibitors of these receptors and provide evidence to support their use as novel therapeutic agents for autoimmunity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1600-065x.2008.00630.x

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 206

Metadata

Authors
Barrat, F. J., & Coffman, R. L.
Venue
Immunological Reviews
Publisher
Wiley
Published
2008-06
Volume
223
Issue
1
Pages
271-283
ISSN
  • 0105-2896 (ISSN-L)
  • 1600-065X
OpenAlex
W2143666663
Cited by
206
References
11
FWCI
1.22
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Development of TLR inhibitors for the treatment of autoimmune diseases. https://app.cochat.ai/papers/10.1111/j.1600-065x.2008.00630.x
The paper
Barrat, F. J., & Coffman, R. L. (2008). Development of TLR inhibitors for the treatment of autoimmune diseases. Immunological Reviews. https://doi.org/10.1111/j.1600-065x.2008.00630.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.